Accrued expenses consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
MARCH 31,
2026 |
|
|
DECEMBER 31,
2025 |
|
Accrued clinical expenses |
|
$ |
9,062 |
|
|
$ |
9,178 |
|
Accrued manufacturing expenses |
|
|
8,159 |
|
|
|
5,889 |
|
Accrued external research and development expenses |
|
|
2,501 |
|
|
|
3,231 |
|
Accrued employee compensation |
|
|
6,254 |
|
|
|
3,658 |
|
Accrued other |
|
|
2,601 |
|
|
|
1,225 |
|
Total |
|
$ |
28,577 |
|
|
$ |
23,181 |
|
|